Skip to main content

Advertisement

Table 2 Quality measures for lateral epicondylalgia care and their reliability

From: Quality measures for the care of patients with lateral epicondylalgia

Clinical quality measures n Kappa index General agreement percentage (%)
Inter-rater Intra-rater Inter-rater Intra-rater
I. Patient exam      
1. Physical examination: percentage of patients with LE for whom the affected tendon was examined (at least orthopedic tests). 80 - - 100 100
2. Pain assessment: percentage of patients with LE who had pain assessment upon initiation of a new treatment. 80 - - 95 100
3. Functional assessment: percentage of patients with LE who had functional assessment upon initiation of a new treatment. 80 - - 85 95
II. Educational interventions      
1. Education: percentage of patients with LE for whom their health provider gave them education and counselling for risk factor reduction strategies. 80 0.8 0.9 - -
III. 1. Pharmacological therapy      
1. Pharmacological therapy for LE: percentage of patients who received pharmacological therapy for LE and who received NSAIDs as first line. 75 - - 100 100
2. Prophylaxis for gastrointestinal bleeding: percentage of patients with NSAIDs for LE who concomitantly received inhibitors (e.g. proton pump inhibitor, misoprostol, etc.). 24 0.9 1 - -
III. 2. Physical therapy      
1. Physical therapy for LE: percentage of patients who received physical therapy for LE and who received a program of exercise therapy as first line. 42 - - 95 100
2. Physical therapy for LE: percentage of patients who received physical therapy for LE and who received manual therapy as first line. 42 0.9 1 - -
3. Physical therapy for LE: percentage of patients who received physical therapy for LE and who received laser therapy as first line. 42 0.9 1 - -
4. Time of referral: percentage of patients with LE who received corticosteroid injection and who initiated a multimodal program of physical therapy within 14 days of the injection. 17 1 1 - -
III. 3. Other therapeutic interventions      
1. Platelet-rich plasma (PRP) therapy for LE: percentage of patients who received PRP therapy for LE and who received PRP therapy as first line (*). 1 N/A. N/A. N/A. N/A.
2. Surgery intervention for LE: percentage of patients who were symptomatic after a minimum of 6–12 months of conservative therapies and who underwent surgery (*). 14 N/A. N/A. N/A. N/A.
  1. N/A. Not applicable.
  2. -: Index not calculated. The general agreement percentage was used when occurrence or absence of evaluated processes of care was higher than 85%.
  3. *.QMs in the text which had slight feasibility problems.